Latest Strategy News

Patagonia Lithium has reached 335 metres depth in its Formentera lithium brine drilling program in Argentina, successfully collecting brine and core samples for detailed analysis. The company plans further drilling and geophysical surveys to refine its Mineral Resource Estimate.

Rent.com.au has seen an 80% exercise rate of its listed options, raising nearly $8 million and securing a robust funding position ahead of expected cashflow break-even. This move underscores strong investor backing and sets the stage for accelerated growth.

Global X Management (AUS) Limited has announced final distribution amounts for 28 ETFs listed on the ASX AQUA Market, revealing a varied payout landscape for the period ending 31 December 2025.

Medallion Metals Limited has opened a Share Purchase Plan offering eligible shareholders in Australia and New Zealand the chance to buy shares at a 20.8% discount, aiming to raise $5 million for advancing its Forrestania and Cosmic Boy projects.

Embark Early Education Limited has initiated an off-market takeover bid for Mayfield Childcare Limited, offering shareholders a choice between scrip or cash consideration at a significant premium. The bid aims to consolidate operations and expand Embark’s footprint across Australia’s childcare sector.

Carbonxt Group Limited has raised $600,000 through a share placement to fund working capital and increase its ownership in New Carbon Processing, LLC to 46.7%. The move supports progress at New Carbon’s Kentucky facility as it nears commissioning.

Temas Resources has fortified its position in the critical minerals sector through key strategic moves including joining Québec’s CSM Scientific Network, engaging market-making services, and commissioning independent equity research.

Asara Resources has released a second tranche of drilling results from its Massan deposit in Guinea, reinforcing the continuity of gold mineralisation and confirming promising depth extensions beyond the current resource model.

BlinkLab Limited has secured independent scientific validation for its smartphone-based autism diagnostic technology through publication in the prestigious journal Autism Research, marking a significant milestone ahead of its FDA regulatory trial.

Island Pharmaceuticals reports ongoing FDA review of its antiviral Galidesivir, with no adverse feedback received as the regulator takes extra time to finalise guidance.

Biome Australia Limited has reported a record-breaking quarter and half-year sales performance, driven by strong demand for its clinically-backed probiotic products. Revenue surged over 40% compared to the previous year, defying typical seasonal slowdowns.

Vanguard Investments Australia has announced final distribution amounts and key dates for 27 of its ETFs, with payments scheduled for mid-January 2026. Investors can also participate in the Distribution Reinvestment Plan across all funds.